Reuters |
New York accuses Insys of deceptively marketing opioid
Reuters (Reuters) - Insys Therapeutics Inc's legal woes deepened on Thursday as New York's attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses ... |
Thursday, February 1, 2018
New York accuses Insys of deceptively marketing opioid - Reuters
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment